Carcinoid syndrome
From WikiAnesthesia
Revision as of 10:26, 3 May 2021 by Nirav Kamdar (talk | contribs) (Introduction and anesthetic implications)
Carcinoid syndrome is caused by neoplasms from neuroendocrine cells that can release vasoactive substances such as serotonin, histamine, dopamine, substance P, prostaglandins, and kallikreins. Systemic manifestations of circulating vasoactive peptides from carcinoid tumors include flushing, wheezing, and diarrhea in addition to hemodynamic changes such as hypertension and hypotension. Carcinoid syndrome can also exacerbate cardiac and right-sided valvular problems.
Carcinoid syndrome
Anesthetic relevance | |
---|---|
Anesthetic management |
{{{anesthetic_management}}} |
Specialty | |
Signs and symptoms | |
Diagnosis | |
Treatment | |
Article quality | |
Editor rating | |
User likes | 0 |
Anesthetic implications
Preoperative optimization
Identify signs of carcinoid-induced cardiac disease and symptoms of neurpeptide release (as well as associated triggers)
Consider pre-operative echocardiography to assess right heart function and tricuspid valve
Intraoperative management
Postoperative management
Related surgical procedures
Pathophysiology
Signs and symptoms
Diagnosis
Treatment
Medication
Surgery
Prognosis
Epidemiology
References
Top contributors: Nirav Kamdar